Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by PrettyPennieson Jun 22, 2018 5:45pm
160 Views
Post# 28216343

RE:Who's interested in us ASK ROGER ABOUT QUEBEC....

RE:Who's interested in us ASK ROGER ABOUT QUEBEC.... Merck bought out Sigma Aldrich within days of Theralase signining on wth Sigma. Coincidence? Probably, these deals take a long time to complete, but it sure was a shock when it happened.

Just something to think about....why did Sanofi quit producing BCG? Is there a production problem there that would also affect Merck? The way I understand it, BCG is a failed (not recommended by CDC) tuberculosis vaccine made from dead TB cells. The cells have to be cultured and killed somewhere, somehow. That stuff is very dangerous! The profit margin would have to be more than significant to warrant that kind of risk.




LaserStock29 wrote: For me the big players appear to be these 3

1. Merck.  

Why?   Sanofi is not producing BCG after Q4 2018 making Merck the 'sole producer'

Relation to TLT;  They bought out Sigma which produces TLD-1433.

Quantum Entanglement factor :  Very strong ****


2. Frost

Why?  Leading and legendary investor in Biotechs and disruptive technologies.  Has a pulse on a distribution and network for getting our drug out there.

Relation to TLT;  Sits on the Chair of Ladenburg Thallman and was 4 million (half) of the first PP 

Quantum Entanglement : Strong ***

3. JSS and Quebec's Government

Why? The Premier of Quebec is a neurosurgeon and big into biotechnologies.  

Relation to TLT;  Roger White has given a pr about the JSS relationship regarding Phase 1,2, etc trials.   Quebec is one of two provinces that endorses the full adoption of PDT.. There are most likely some deep pockets in Quebec. 

Quantum Entanglement: Strong ***


So Roger.. What's it' gonna be... we're worth 500m to 1b  right now in Market cap... there's no justification for a small pp.. when there are incentive deals with a JV

Other Pharma drugs perform like garbage anyways.. and we have sent 3 home no problems.. from loss of organ or death essentially. 

That's worth something. 


Cheers all. 


Bullboard Posts